$ABT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABBOTT LABORATORIES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ABBOTT LABORATORIES. Get notifications about new insider transactions in ABBOTT LABORATORIES for free.
Page: < prev 1 ... 8 9 10 11 12 13 14 15 16 ... 53 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 27.03 | 44,000 | 1,189,478 | 0 | |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 22.39 | 45,800 | 1,025,549 | 0 | |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 26.19 | 28,700 | 751,593 | 0 | |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 26.02 | 38,700 | 1,006,781 | 0 | |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 26.70 | 39,350 | 1,050,539 | 0 | |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 46.00 | 195,700 | 9,002,200 | 182,138 | 377.8 K to 182.1 K (-51.79 %) |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 46.01 | 300 | 13,803 | 377,838 | 378.1 K to 377.8 K (-0.08 %) |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 46.02 | 500 | 23,010 | 378,138 | 378.6 K to 378.1 K (-0.13 %) |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 46.93 | 50 | 2,347 | 378,638 | 378.7 K to 378.6 K (-0.01 %) |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 27.03 | 44,000 | 1,189,478 | 378,688 | 334.7 K to 378.7 K (+13.15 %) |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 22.39 | 45,800 | 1,025,549 | 334,688 | 288.9 K to 334.7 K (+15.85 %) |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 26.19 | 28,700 | 751,593 | 288,888 | 260.2 K to 288.9 K (+11.03 %) |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 26.02 | 38,700 | 1,006,781 | 260,188 | 221.5 K to 260.2 K (+17.47 %) |
| Jun 09 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 26.70 | 39,350 | 1,050,539 | 221,488 | 182.1 K to 221.5 K (+21.60 %) |
| Jun 02 2017 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Payment of Exercise | F | 45.66 | 352 | 16,072 | 53,784 | 54.1 K to 53.8 K (-0.65 %) |
| Jun 02 2017 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Payment of Exercise | F | 45.66 | 602 | 27,487 | 22,893 | 23.5 K to 22.9 K (-2.56 %) |
| Jun 02 2017 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Grant | A | 0.00 | 3,007 | 0 | 23,495 | 20.5 K to 23.5 K (+14.68 %) |
| Jun 02 2017 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Payment of Exercise | F | 45.66 | 1,767 | 80,681 | 61,658 | 63.4 K to 61.7 K (-2.79 %) |
| May 17 2017 | ABT | ABBOTT LABORATORIE ... | Shrimpton Sean | Senior Vice Preside ... | Option Exercise | A | 44.08 | 92,032 | 4,056,771 | 92,032 | |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Grant | A | 0.00 | 3,437 | 0 | 6,462,940 | 6.5 M to 6.5 M (+0.05 %) |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 3,437 | 0 | 35,867 | 32.4 K to 35.9 K (+10.60 %) |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | SCOTT SAMUEL C III | Director | Option Exercise | A | 43.64 | 18,148 | 791,979 | 18,148 | |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | SCOTT SAMUEL C III | Director | Grant | A | 0.00 | 3,437 | 0 | 34,867 | 31.4 K to 34.9 K (+10.94 %) |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Option Exercise | A | 43.64 | 21,448 | 935,991 | 21,448 | |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Grant | A | 0.00 | 3,437 | 0 | 51,137 | 47.7 K to 51.1 K (+7.21 %) |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | NOVAKOVIC PHEBE N | Director | Option Exercise | A | 43.64 | 19,385 | 845,961 | 19,385 | |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | NOVAKOVIC PHEBE N | Director | Grant | A | 0.00 | 3,437 | 0 | 21,147 | 17.7 K to 21.1 K (+19.41 %) |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | LIDDY EDWARD M | Director | Option Exercise | A | 43.64 | 19,890 | 868,000 | 19,890 | |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | LIDDY EDWARD M | Director | Grant | A | 0.00 | 3,437 | 0 | 21,782 | 18.3 K to 21.8 K (+18.74 %) |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | McKinstry Nancy | Director | Option Exercise | A | 43.64 | 18,148 | 791,979 | 18,148 | |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | McKinstry Nancy | Director | Grant | A | 0.00 | 3,437 | 0 | 18,480 | 15 K to 18.5 K (+22.85 %) |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | Blount Sally E. | Director | Grant | A | 0.00 | 3,437 | 0 | 23,580 | 20.1 K to 23.6 K (+17.06 %) |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | AUSTIN ROXANNE S | Director | Option Exercise | A | 43.64 | 20,852 | 909,981 | 20,852 | |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | AUSTIN ROXANNE S | Director | Grant | A | 0.00 | 3,437 | 0 | 39,727 | 36.3 K to 39.7 K (+9.47 %) |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Grant | A | 0.00 | 3,437 | 0 | 25,220 | 21.8 K to 25.2 K (+15.78 %) |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | NATH DEEPAK S. | Senior Vice Preside ... | Payment of Exercise | F | 43.65 | 189 | 8,250 | 51,241 | 51.1 K to 51.2 K (+0.37 %) |
| Apr 28 2017 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Sell | S | 43.82 | 5,600 | 245,393 | 51,313 | 56.9 K to 51.3 K (-9.84 %) |
| Apr 28 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Option Exercise | M | 26.70 | 3,200 | 85,431 | 0 | |
| Apr 28 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 43.97 | 600 | 26,384 | 22,024 | 22.6 K to 22 K (-2.65 %) |
| Apr 28 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 43.97 | 400 | 17,588 | 22,624 | 23 K to 22.6 K (-1.74 %) |
| Apr 28 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 43.95 | 2,300 | 101,078 | 23,024 | 25.3 K to 23 K (-9.08 %) |
| Apr 28 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 43.95 | 500 | 21,973 | 25,324 | 25.8 K to 25.3 K (-1.94 %) |
| Apr 28 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 43.94 | 100 | 4,394 | 25,824 | 25.9 K to 25.8 K (-0.39 %) |
| Apr 28 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 43.94 | 100 | 4,394 | 25,924 | 26 K to 25.9 K (-0.38 %) |
| Apr 28 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 43.94 | 200 | 8,788 | 26,024 | 26.2 K to 26 K (-0.76 %) |
| Apr 28 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Buy | M | 26.70 | 3,200 | 85,431 | 26,224 | 23 K to 26.2 K (+13.90 %) |
| Apr 04 2017 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Option Exercise | A | 44.36 | 34,424 | 1,527,049 | 34,424 | |
| Apr 04 2017 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 743 | 0 | 29,265 | |
| Apr 04 2017 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 177 | 0 | 6,121 | |
| Mar 24 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Gift | G | 0.00 | 394 | 0 | 64,297 | 63.9 K to 64.3 K (+0.62 %) |
| Mar 24 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Gift | G | 0.00 | 394 | 0 | 45,339 | 45.7 K to 45.3 K (-0.86 %) |
| Mar 24 2017 | ABT | ABBOTT LABORATORIE ... | ABBOTT LABORATORIES | 10% Owner | Sell | S | 41.60 | 44,000,000 | 1,830,400,000 | 25,750,000 | 69.8 M to 25.8 M (-63.08 %) |
| Mar 17 2017 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Gift | G | 0.00 | 10,670 | 0 | 80,212 | 69.5 K to 80.2 K (+15.34 %) |
| Mar 17 2017 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Gift | G | 0.00 | 10,670 | 0 | 54,136 | 64.8 K to 54.1 K (-16.46 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Sell | S | 45.39 | 1,728 | 78,434 | 63,425 | 65.2 K to 63.4 K (-2.65 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Payment of Exercise | F | 45.46 | 4,227 | 192,159 | 65,153 | 69.4 K to 65.2 K (-6.09 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 44.96 | 1 | 45 | 23,024 | 23 K to 23 K (0.00 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 44.96 | 300 | 13,489 | 23,025 | 23.3 K to 23 K (-1.29 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 44.96 | 56 | 2,518 | 23,325 | 23.4 K to 23.3 K (-0.24 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 44.96 | 387 | 17,401 | 23,381 | 23.8 K to 23.4 K (-1.63 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Payment of Exercise | F | 45.46 | 1,463 | 66,508 | 23,768 | 25.2 K to 23.8 K (-5.80 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Grant | A | 45.46 | 5,085 | 231,164 | 25,231 | 20.1 K to 25.2 K (+25.24 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | NATH DEEPAK S. | Senior Vice Preside ... | Sell | S | 45.39 | 1,601 | 72,669 | 51,430 | 53 K to 51.4 K (-3.02 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | NATH DEEPAK S. | Senior Vice Preside ... | Payment of Exercise | F | 45.46 | 4,302 | 195,569 | 53,031 | 57.3 K to 53 K (-7.50 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Sell | S | 45.39 | 2,066 | 93,776 | 72,112 | 74.2 K to 72.1 K (-2.79 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Payment of Exercise | F | 45.46 | 4,759 | 216,344 | 74,178 | 78.9 K to 74.2 K (-6.03 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Sell | S | 45.01 | 857 | 38,569 | 100,879 | 101.7 K to 100.9 K (-0.84 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Payment of Exercise | F | 45.46 | 10,876 | 494,423 | 101,736 | 112.6 K to 101.7 K (-9.66 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Payment of Exercise | F | 45.46 | 13,259 | 602,754 | 158,154 | 171.4 K to 158.2 K (-7.74 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 45.46 | 10,815 | 491,650 | 277,982 | 288.8 K to 278 K (-3.74 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Sell | S | 45.39 | 970 | 44,028 | 48,511 | 49.5 K to 48.5 K (-1.96 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Payment of Exercise | F | 45.46 | 2,496 | 113,468 | 49,481 | 52 K to 49.5 K (-4.80 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Payment of Exercise | F | 45.46 | 3,742 | 170,111 | 88,337 | 92.1 K to 88.3 K (-4.06 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Payment of Exercise | F | 45.46 | 11,380 | 517,335 | 182,138 | 193.5 K to 182.1 K (-5.88 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Payment of Exercise | F | 45.46 | 59,192 | 2,690,868 | 3,143,077 | 3.2 M to 3.1 M (-1.85 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Warmuth Michael J | Executive Vice Pres ... | Sell | S | 45.39 | 3,851 | 174,797 | 56,508 | 60.4 K to 56.5 K (-6.38 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Warmuth Michael J | Executive Vice Pres ... | Payment of Exercise | F | 45.46 | 8,881 | 403,730 | 60,359 | 69.2 K to 60.4 K (-12.83 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Warmuth Michael J | Executive Vice Pres ... | Grant | A | 0.00 | 26,367 | 0 | 69,240 | 42.9 K to 69.2 K (+61.50 %) |
| Feb 24 2017 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | M | 26.70 | 25,500 | 680,781 | 0 | |
| Feb 24 2017 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Sell | S | 45.50 | 25,500 | 1,160,250 | 92,079 | 117.6 K to 92.1 K (-21.69 %) |
| Feb 24 2017 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Buy | M | 26.70 | 25,500 | 680,781 | 117,579 | 92.1 K to 117.6 K (+27.69 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Option Exercise | A | 44.40 | 92,032 | 4,086,221 | 92,032 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Sell | S | 44.98 | 146 | 6,567 | 20,146 | 20.3 K to 20.1 K (-0.72 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Payment of Exercise | F | 44.69 | 287 | 12,826 | 20,292 | 20.6 K to 20.3 K (-1.39 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Warmuth Michael J | Executive Vice Pres ... | Option Exercise | A | 44.40 | 205,023 | 9,103,021 | 205,023 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | A | 44.40 | 182,242 | 8,091,545 | 182,242 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Grant | A | 0.00 | 26,351 | 0 | 171,413 | 145.1 K to 171.4 K (+18.17 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Option Exercise | A | 44.40 | 138,049 | 6,129,376 | 138,049 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Grant | A | 0.00 | 19,961 | 0 | 78,937 | 59 K to 78.9 K (+33.85 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Option Exercise | A | 44.40 | 167,056 | 7,417,286 | 167,056 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Grant | A | 0.00 | 24,155 | 0 | 112,612 | 88.5 K to 112.6 K (+27.31 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Option Exercise | A | 44.40 | 638,629 | 28,355,128 | 638,629 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Grant | A | 0.00 | 92,342 | 0 | 3,202,269 | 3.1 M to 3.2 M (+2.97 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Option Exercise | A | 44.40 | 136,682 | 6,068,681 | 136,682 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Grant | A | 0.00 | 19,763 | 0 | 69,380 | 49.6 K to 69.4 K (+39.83 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Senior Vice Preside ... | Option Exercise | A | 44.40 | 112,484 | 4,994,290 | 112,484 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Senior Vice Preside ... | Payment of Exercise | F | 44.69 | 605 | 27,037 | 15,176 | 15.8 K to 15.2 K (-3.83 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | A | 44.40 | 48,831 | 2,168,096 | 48,831 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Grant | A | 0.00 | 7,060 | 0 | 92,079 | 85 K to 92.1 K (+8.30 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Mason Heather L | Executive Vice Pres ... | Option Exercise | A | 44.40 | 38,940 | 1,728,936 | 38,940 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Mason Heather L | Executive Vice Pres ... | Grant | A | 0.00 | 5,630 | 0 | 70,119 | 64.5 K to 70.1 K (+8.73 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | NATH DEEPAK S. | Senior Vice Preside ... | Option Exercise | A | 44.40 | 76,693 | 3,405,169 | 76,693 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | NATH DEEPAK S. | Senior Vice Preside ... | Sell | S | 44.98 | 319 | 14,349 | 57,333 | 57.7 K to 57.3 K (-0.55 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | NATH DEEPAK S. | Senior Vice Preside ... | Payment of Exercise | F | 44.69 | 819 | 36,601 | 57,652 | 58.5 K to 57.7 K (-1.40 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | NATH DEEPAK S. | Senior Vice Preside ... | Grant | A | 0.00 | 11,089 | 0 | 58,471 | 47.4 K to 58.5 K (+23.40 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Option Exercise | A | 44.40 | 151,869 | 6,742,984 | 151,869 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Grant | A | 0.00 | 21,959 | 0 | 73,491 | 51.5 K to 73.5 K (+42.61 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | A | 44.40 | 182,242 | 8,091,545 | 182,242 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Grant | A | 0.00 | 26,351 | 0 | 193,518 | 167.2 K to 193.5 K (+15.76 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | A | 44.40 | 138,049 | 6,129,376 | 138,049 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Grant | A | 0.00 | 19,961 | 0 | 67,628 | 47.7 K to 67.6 K (+41.88 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Fain Eric S | Senior Vice Preside ... | Option Exercise | A | 44.40 | 159,657 | 7,088,771 | 159,657 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Fain Eric S | Senior Vice Preside ... | Grant | A | 0.00 | 23,085 | 0 | 544,052 | 521 K to 544.1 K (+4.43 %) |
| Feb 15 2017 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Option Exercise | M | 25.25 | 3,400 | 85,837 | 0 | |
| Feb 15 2017 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Sell | S | 43.00 | 3,400 | 146,200 | 88,457 | 91.9 K to 88.5 K (-3.70 %) |
| Feb 15 2017 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Buy | M | 25.25 | 3,400 | 85,837 | 91,857 | 88.5 K to 91.9 K (+3.84 %) |
| Feb 07 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Option Exercise | M | 25.25 | 300 | 7,574 | 0 | |
| Feb 07 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Payment of Exercise | F | 42.75 | 213 | 9,106 | 20,579 | 20.8 K to 20.6 K (-1.02 %) |
| Feb 07 2017 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Buy | M | 25.25 | 300 | 7,574 | 20,792 | 20.5 K to 20.8 K (+1.46 %) |
| Feb 02 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | P | 40.77 | 12,200 | 497,394 | 167,167 | 155 K to 167.2 K (+7.87 %) |
| Feb 02 2017 | ABT | ABBOTT LABORATORIE ... | Mason Heather L | Executive Vice Pres ... | Option Exercise | M | 25.25 | 35,700 | 901,286 | 0 | |
| Feb 02 2017 | ABT | ABBOTT LABORATORIE ... | Mason Heather L | Executive Vice Pres ... | Sell | S | 40.77 | 35,700 | 1,455,489 | 64,489 | 100.2 K to 64.5 K (-35.63 %) |
| Feb 02 2017 | ABT | ABBOTT LABORATORIE ... | Mason Heather L | Executive Vice Pres ... | Buy | M | 25.25 | 35,700 | 901,286 | 100,189 | 64.5 K to 100.2 K (+55.36 %) |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | ROUSSEAU MICHAEL T | Pres., Cardiovasc. ... | Option Exercise | A | 29.56 | 545,573 | 16,127,138 | 545,573 | |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | ROUSSEAU MICHAEL T | Pres., Cardiovasc. ... | Option Exercise | A | 33.14 | 150,737 | 4,995,424 | 150,737 | |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | ROUSSEAU MICHAEL T | Pres., Cardiovasc. ... | Option Exercise | A | 28.50 | 77,739 | 2,215,562 | 77,739 | |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | ROUSSEAU MICHAEL T | Pres., Cardiovasc. ... | Grant | A | 0.00 | 429,095 | 0 | 632,581 | 203.5 K to 632.6 K (+210.87 %) |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | ROUSSEAU MICHAEL T | Pres., Cardiovasc. ... | Grant | A | 0.00 | 17,083 | 0 | 203,486 | 186.4 K to 203.5 K (+9.16 %) |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | ROUSSEAU MICHAEL T | Pres., Cardiovasc. ... | Grant | A | 0.00 | 84,394 | 0 | 186,403 | 102 K to 186.4 K (+82.73 %) |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | ROUSSEAU MICHAEL T | Pres., Cardiovasc. ... | Grant | A | 0.00 | 61,275 | 0 | 102,010 | 40.7 K to 102 K (+150.42 %) |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | ROUSSEAU MICHAEL T | Pres., Cardiovasc. ... | Grant | A | 0.00 | 40,735 | 0 | 40,735 | 0 to 40.7 K |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | Fain Eric S | Senior Vice Preside ... | Option Exercise | A | 29.56 | 163,268 | 4,826,202 | 163,268 | |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | Fain Eric S | Senior Vice Preside ... | Option Exercise | A | 33.14 | 85,864 | 2,845,533 | 85,864 | |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | Fain Eric S | Senior Vice Preside ... | Option Exercise | A | 28.50 | 44,387 | 1,265,030 | 44,387 | |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | Fain Eric S | Senior Vice Preside ... | Grant | A | 0.00 | 32,418 | 0 | 520,968 | 488.6 K to 521 K (+6.64 %) |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | Fain Eric S | Senior Vice Preside ... | Grant | A | 0.00 | 50,761 | 0 | 488,549 | 437.8 K to 488.5 K (+11.59 %) |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | Fain Eric S | Senior Vice Preside ... | Grant | A | 0.00 | 322,461 | 0 | 437,788 | 115.3 K to 437.8 K (+279.61 %) |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | Fain Eric S | Senior Vice Preside ... | Grant | A | 0.00 | 113,827 | 0 | 115,327 | 1.5 K to 115.3 K (+7,588.47 %) |
| Jan 06 2017 | ABT | ABBOTT LABORATORIE ... | Warmuth Michael J | Executive Vice Pres ... | Grant | A | 0.00 | 15 | 0 | 42,874 | 42.9 K to 42.9 K (+0.03 %) |
| Jan 04 2017 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 205 | 0 | 5,908 | |
| Jan 04 2017 | ABT | ABBOTT LABORATORIE ... | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 859 | 0 | 20,113 | |
| Jan 04 2017 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 859 | 0 | 28,351 | |
| Jan 04 2017 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Option Exercise | A | 0.00 | 1,015 | 0 | 26,963 | |
| Dec 21 2016 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | P | 38.44 | 100 | 3,844 | 145,062 | 145 K to 145.1 K (+0.07 %) |
| Dec 21 2016 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | P | 38.44 | 2,072 | 79,648 | 144,962 | 142.9 K to 145 K (+1.45 %) |
| Dec 21 2016 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | P | 38.45 | 3,400 | 130,730 | 142,890 | 139.5 K to 142.9 K (+2.44 %) |
| Dec 21 2016 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | P | 38.46 | 9,708 | 373,370 | 139,490 | 129.8 K to 139.5 K (+7.48 %) |
| Dec 21 2016 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | P | 38.43 | 300 | 11,529 | 129,782 | 129.5 K to 129.8 K (+0.23 %) |
| Dec 16 2016 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Gift | G | 0.00 | 340 | 0 | 9,512 | 9.2 K to 9.5 K (+3.71 %) |
| Dec 16 2016 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Gift | G | 0.00 | 340 | 0 | 9,498 | 9.2 K to 9.5 K (+3.71 %) |